Biopharma Deals of 2024 | History of Alzheimer’s disease | Trends in Clinical-Trial Reporting
 
The latest from partnerships.nature.com
 
 
 
 
  Insights
 
 
 
The Most Impactful Biopharma Deals of 2024
The Biopharma Dealmakers issue highlights the top ten biopharma partnerships of 2024, valued at $31 billion. Cancer therapies lead six of these deals. Despite fewer blockbuster agreements than in 2023, strong investments in protein drugs and early-stage platforms show the industry's ongoing drive for innovation. Read more.
 
The history of Alzheimer’s disease
Don't miss out on this year's Nature Milestones issue, which focus on the significant advancements in Alzheimer's disease research! Read more.
 
Rising Trends in Clinical-Trial Reporting
Nature Spotlight on "Bench to Bedside" issue highlights the push for transparency in clinical trials. Despite progress, challenges persist, especially in some countries and publicly funded trials.  Read more.
 
The Secret Life of Gut Viruses
Nature Outlook on "The human microbiome" delves into the intriguing and mostly unknown realm of bacteriophages—viruses that live alongside bacteria in our gut. Although they are the most numerous biological entities on Earth, the diversity and roles of phages in the human gut microbiome are still largely mysterious. Read more.
 
 
 
  Audiences
 
 
 
Life and physical scientists
We release more than 1,600 journals in the fields of life and physical sciences, enabling your brand to reach a global audience. Read more.
 
Healthcare professionals (HCPs) 
Engage with the vast HCP network who are reading our 1,000 clinical medicine journals. Read more.
 
 
Nature Careers (banner)
 
 
 
 
  Opportunities
 
 
 
Partner on a Nature Conference in 2025
Work with Nature editors on your conference program. Read more.
 
Book your spot in Biopharma Dealmakers 2025 issues
Don't miss the January deadlines to participate in our Precision medicine – including genetic sequencing, gene editing and molecular diagnostics.  Read more.
 
Connect with your specialized audience in a webcast
Engage Nature scientists with your research and generate high-quality leads for your sales team.Read more.
 
Submit your case study
Complete our quick form to share your success with our global audience. Read more.
 
 
Nature Digital Advertising
 
 
 
Nature Masterclasses workshops (banner)
 
 
 
 
 
Would any of your colleagues or friends benefit from our monthly newsletter? Please invite them to subscribe here.
 
 
 
 
 
 
  Media kits
 
 
 
 
 
  Services
 
 
 
 
 
   
 
 
 
 
Image
 
Follow us at @NaturePortfolio
 
 
Image
 
Visit our Nature Facebook Page
 
 
Image
 
Visit us at LinkedIn NaturePortfolio
 
 
 
 
 
© Nature Portfolio
 
 
 
This email has been sent to .

As a registered user of Nature Portfolio websites, our database indicates that you have opted-in to receive product information and special offers. If you no longer wish to receive these marketing emails from Nature Portfolio please click here to unsubscribe.

If you wish to discontinue all email services from Nature Portfolio please click here to unsubscribe
 
Springer Nature Limited is a company incorporated in England & Wales under company number 785998 & whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW. Nature Portfolio | One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA
 
LinkedIn
 
© 2025  Nature Portfolio. Part of Springer Nature. All rights reserved.  
 
 
 
 
© Nature Portfolio
 
 
 
This email has been sent to .

If you no longer wish to receive these marketing emails from Nature Portfolio please click here to unsubscribe.

 
Springer Nature Limited is a company incorporated in England & Wales under company number 785998 & whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW. Nature Portfolio | One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA
 
LinkedIn
 
© 2025  Nature Portfolio. Part of Springer Nature. All rights reserved.